AI Article Synopsis
- Mesenteric panniculitis is a rare, chronic inflammatory condition affecting the mesentery's fat tissue, often presenting with symptoms like abdominal pain and requiring imaging for diagnosis.* -
- A case study highlighted a patient treated with oral prednisone, showing significant symptom relief and moderate weight gain within a month.* -
- Current treatment options are mainly immunosuppressive or anti-inflammatory medications, with a generally good prognosis and rare recurrence.*
Article Abstract
Mesenteric panniculitis is a rare, slowly progressive, benign, and chronic fibrous inflammatory disease that affects the adipose tissue of the mesentery. In the present study, we aim to investigate its clinical presentations, computed tomography/sonography scan features, effectiveness of the treatment, and overall prognosis. We investigated various presentations, etiologies, diagnostic approaches, potential treatment modalities, and overall prognosis of mesenteric panniculitis. We present one case of mesenteric panniculitis with abdominal pain, which underwent steroid treatment regimens subsequently and gained weight moderately. An abdomen and pelvis cavity computed tomography scan showed misty mesentery, an ill-defined increase in the density of the peritoneal fat at the base of the mesentery with few small associated lymph nodes. The appearance is that of a panniculitis. His symptoms gradually decreased in intensity and disappeared totally within 1 month after oral prednisone 40 mg per day and moderate gain weight. Computed tomography scan features of the disease have recently been delineated clearly. Standard treatment strategy does not exist, and the current ways mainly consist of immunosuppressor or anti-inflammation agents. Overall prognosis is usually good and recurrence seems to be rare.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/SGA.0000000000000596 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Gastric Outlet Obstruction as a First Symptom of a Non-Muscle Invasive Bladder Cancer (NMIBC) Progression-A Case Report.
Cancer Rep (Hoboken)
December 2024
Department of Internal Medicine, Hospital St. Josef Braunau, Braunau am Inn, Austria.
Article Synopsis
- A 78-year-old male patient presented with persistent vomiting due to a rare case of metastatic urinary bladder cancer, which led to gastric outlet obstruction.
- Despite recent follow-up showing no disease recurrence, tests revealed duodenal stenosis and abnormal mesenteric fat swelling, initially misinterpreted as inflammation.
- A laparoscopic exploration confirmed peritoneal carcinomatosis, ultimately identifying urothelial cancer cells, highlighting the need for clinicians to think about metastatic bladder cancer in similar situations.
A Case Report of Mesenteric Panniculitis and Fibrous Dysplasia with Primary Metabolic Syndrome.
Eur J Case Rep Intern Med
November 2024
College of Medicine, University of Nebraska Medical Center, Omaha, USA.
Introduction: Mesenteric panniculitis (MP) is a rare clinically diagnosed disease resulting from fibro-inflammation in the intestinal adipose tissue. Precedent intra-abdominal inflammation or trauma is often evident. Fibrous dysplasia (FD) is a benign uncommon childhood disease of the bones, with fibrous connective tissue replacing bone tissue.
View Article and Find Full Text PDFUpper and Lower Endoscopic Findings in Mesenteric Panniculitis Patients: A Case-Control Study.
J Clin Med
November 2024
Gastroenterology Division Rabin Medical Center-Beilinson Hospital, Petach Tikva 4941492, Israel.
: The natural history and prognosis of mesenteric panniculitis (MP) are not well-described. Despite referral for colonoscopy being common for this indication, colonoscopy findings in MP patients have not been reported. Therefore, we aimed to describe upper and lower gastrointestinal (GI) endoscopy findings in patients with mesenteric panniculitis, compared to matched controls, to investigate their clinical outcomes including incidence of malignancy and mortality.
View Article and Find Full Text PDFInflammatory Mesenteric Disease and Sarcoidosis-like Reaction in a Patient with Lung Adenocarcinoma Who Received Pembrolizumab: Paraneoplastic Syndrome, Secondary to Checkpoint Inhibitor or Chance Finding?
Curr Oncol
November 2024
Medical Oncology Department, University Hospital of Salamanca, 37007 Salamanca, Spain.
: Anti PD1/PD-L1 agents, including pembrolizumab, have revolutionized the oncological treatment of different types of cancer, including non-small cell lung cancer. The most frequent complications associated with this type of treatment are mild and are located at the thyroid, pulmonary or hepatic level. Sarcoid like reaction and mesenteric panniculitis secondary to pembrolizumab treatment are two very rare adverse effects.
View Article and Find Full Text PDFErythema nodosum as first clinical manifestation of metastatic neuroendocrine tumor: A case report.
Heliyon
October 2024
Fundación Valle Del Lili, Unit of Rheumatology, Cali, 760031, Colombia.
Erythema nodosum (EN) is a reactive inflammatory panniculitis, which has been associated with medications, infections, autoimmune and autoinflammatory diseases. It has rarely been associated with neoplasms. We present the case of a 61-year old woman who was admitted because 3-week history of painful erythematous subcutaneous nodules on the lower limbs clinically consistent with EN, which was confirmed by skin biopsy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!